Does a Laparoscopic Approach to Distal Pancreatectomy for Cancer Contribute to Optimal Adjuvant Chemotherapy Utilization?
Omar Slaehi, Eduardo A. Vega, Onur C. Kutlu, Sanjay Krishnan, David Sleeman, Nestor de la Cruz-Muñoz, Sergio Alarcon, Veronika Kazakova, Olga Kozyreva, Claudius Conrad
- Chemotherapy after pancreatic cancer surgery can significantly improve survival, but many patients who undergo open surgery recover too slowly to start on time. This study examined whether laparoscopic surgery helps more patients receive their full course of chemotherapy.
- Laparoscopic pancreas surgery offers smaller incisions, less blood loss, shorter hospital stays, and faster recovery, which matters because faster recovery means sooner chemotherapy.
- Pancreatic cancer remains challenging to treat; this study addresses whether surgical technique influences a patient's ability to complete their full treatment plan.
- Dr. de la Cruz-Muñoz's involvement reflects expertise in advanced laparoscopic surgery beyond weight loss procedures, sought by cancer surgery specialists.
- Published in Annals of Surgical Oncology, the most prestigious surgical oncology journal in the world.
- This is part of a two-paper series demonstrating contributions to advanced laparoscopic surgical oncology.
This study published in Annals of Surgical Oncology examined whether a laparoscopic approach to distal pancreatectomy for pancreatic cancer contributes to higher rates of optimal adjuvant chemotherapy utilization compared with open surgery. The study hypothesized that the laparoscopic approach's faster recovery would enable more patients to receive adjuvant chemotherapy on time. This has significant implications for oncologic outcomes, as timely chemotherapy is associated with better survival in pancreatic cancer. Dr. de la Cruz-Muñoz is a co-author.
Slaehi O, Vega EA, Kutlu OC, Krishnan S, Sleeman D, de la Cruz-Muñoz N, Alarcon S, Kazakova V, Kozyreva O, Conrad C. Does a Laparoscopic Approach to Distal Pancreatectomy for Cancer Contribute to Optimal Adjuvant Chemotherapy Utilization? Annals of Surgical Oncology. 2021. doi:10.1245/s10434-021-10241-5.
